Gamze Guney Eskiler Selected Research

Therapeutics

2/2022	Effectiveness of 5-Fluorouracil and gemcitabine hydrochloride loaded iron‑based chitosan-coated MIL-100 composite as an advanced, biocompatible, pH-sensitive and smart drug delivery system on breast cancer therapy.
1/2022	Therapeutic potential of the PI3K inhibitor LY294002 and PARP inhibitor Talazoparib combination in BRCA-deficient triple negative breast cancer cells.
1/2022	Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
8/2019	Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor-positive breast and prostate cancer cells.
5/2018	Triple negative breast cancer: new therapeutic approaches and BRCA status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gamze Guney Eskiler Research Topics

Disease

21	Neoplasms (Cancer) 01/2024 - 10/2018
15	Breast Neoplasms (Breast Cancer) 02/2023 - 12/2016
14	Triple Negative Breast Neoplasms 03/2023 - 05/2018
8	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 10/2018
2	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 07/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2024
1	Liposarcoma 02/2023
1	Chondrosarcoma 02/2023
1	Sarcoma (Soft Tissue Sarcoma) 02/2023
1	Osteosarcoma (Osteogenic Sarcoma) 02/2023
1	Genomic Instability 01/2023
1	Infections 03/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2020
7	Therapeutic UsesIBA 03/2022 - 09/2020
6	talazoparibIBA 01/2022 - 09/2018
5	AcidsIBA 02/2023 - 09/2020
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2023 - 09/2020
4	Hormones (Hormone)IBA 01/2023 - 10/2018
3	Acridine OrangeIBA 02/2023 - 01/2022
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 05/2019
3	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022 - 04/2020
3	Tamoxifen FDA LinkGeneric 08/2019 - 12/2016
3	usnic acidIBA 08/2019 - 10/2018
2	Annexin A5IBA 02/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 02/2023 - 01/2020
2	Gemcitabine FDA Link 02/2022 - 01/2022
2	cabazitaxel FDA Link 02/2022 - 07/2021
2	CurcuminIBA 01/2022 - 01/2020
2	abemaciclibIBA 01/2022 - 09/2021
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022 - 09/2021
2	nobiletinIBA 04/2020 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 07/2019 - 01/2019
2	Lipid NanoparticlesIBA 09/2018 - 07/2018
1	Bee Venoms (Bee Venom)IBA 03/2023
1	Propidium (Propidium Iodide)IBA 02/2023
1	Caspase 3 (Caspase-3)IBA 02/2023
1	Caspase 9IBA 02/2023
1	tyrosine receptor (receptor, tyrosine)IBA 02/2023
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2023
1	Phosphotransferases (Kinase)IBA 02/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2022
1	Matrix Metalloproteinases (MMPs)IBA 07/2022
1	Tissue Inhibitor of Metalloproteinase-2IBA 07/2022
1	Fluorouracil (Carac)FDA LinkGeneric 02/2022
1	ChitosanIBA 02/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	OligodeoxyribonucleotidesIBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Poly I-CIBA 01/2022
1	Metal-Organic FrameworksIBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	CPG-oligonucleotideIBA 01/2022
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2022
1	1-methyltryptophanIBA 10/2021
1	CytokinesIBA 10/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2021
1	vulpinic acidIBA 08/2021
1	sulfosalicylic acidIBA 08/2021
1	taxaneIBA 07/2021
1	Toll-Like Receptor 4IBA 07/2021
1	CateninsIBA 02/2021
1	Histone Deacetylase InhibitorsIBA 02/2021
1	Histones (Histone)IBA 02/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2021
1	protoporphyrin IXIBA 09/2020
1	FlavonoidsIBA 04/2020
1	multidrug resistance-associated protein 1IBA 01/2020
1	enzalutamideIBA 08/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019

Therapy/Procedure

5	Photochemotherapy (Photodynamic Therapy) 02/2023 - 09/2020
5	Therapeutics 02/2022 - 05/2018
3	Castration 02/2022 - 07/2021
2	Neoadjuvant Therapy 02/2023 - 07/2022
2	Drug Therapy (Chemotherapy) 07/2022 - 07/2019
1	Radiotherapy 01/2024
1	Aftercare (After-Treatment) 07/2022
1	Immunotherapy 10/2021
1	Lasers (Laser) 09/2020
1	Semiconductor Lasers 09/2020